| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 01/16/2003 | WO2001059060A3 Apparatus and method for surface culture of microorganisms from bulk fluids |
| 01/16/2003 | WO2001058954A9 Trade molecules and uses related thereto |
| 01/16/2003 | WO2001055443A9 Crystallization and structure determination of staphylococcus aureus nad synthetase |
| 01/16/2003 | WO2001053529A3 RAPID DETERMINATION OF GENE STRUCTURE USING cDNA SEQUENCE |
| 01/16/2003 | US20030014193 Analysis of catalysed reactions by calorimentry |
| 01/16/2003 | US20030013867 Translation enhancer element of the human amyloid precursor protein gene |
| 01/16/2003 | US20030013866 Eukaryotic cells expressing the receptor |
| 01/16/2003 | US20030013651 Stimulation of osteogenesis using rank ligand fusion proteins |
| 01/16/2003 | US20030013649 Hybrid polypeptide |
| 01/16/2003 | US20030013638 P27 prevents cellular migration |
| 01/16/2003 | US20030013636 Prevent biosynthesis of galactoside |
| 01/16/2003 | US20030013182 Isolation of gene expressing preferential polypeptide; obtain nucleotide sequences, incubate with probes, monitor gene expression isolatea gene from microorganism |
| 01/16/2003 | US20030013181 Novel nucleic acids and polypeptides related to a farnesyl-directed endopeptidase |
| 01/16/2003 | US20030013176 Enzymatic crystal of preferential protein for use in evaluating inhibitor binding activity |
| 01/16/2003 | US20030013156 Peptide for use in the treatment of cell prliferation disorders |
| 01/16/2003 | US20030013153 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/16/2003 | US20030013149 Quantitative analysis |
| 01/16/2003 | US20030013145 Personal breast cancer indicator |
| 01/16/2003 | US20030013144 Detection of modulator of cancer activity; obtain sample containing biopolymers, incubate with modulator, monitor cellular response |
| 01/16/2003 | US20030013143 Methods for identifying vasoprotective agents |
| 01/16/2003 | US20030013141 Process for the discrimination of igg-producing cells from non-igg-producing cells |
| 01/16/2003 | US20030013140 Method of detecting ligand or ligand-like low-molecular weight compound |
| 01/16/2003 | US20030013139 Transgenic cells for use as diagnostic tools in genetic engineering |
| 01/16/2003 | US20030013138 Detection of preferential cell surface proteins; obtain cells, expose to label, detect labelled proteins on cell surface |
| 01/16/2003 | US20030013137 Detection of G protein-coupled receptor activity in cell; obtain cell, incubate with moulator, monitor receptor activity, generate image, determine position of bninding site |
| 01/16/2003 | US20030013136 Detection of modulator of membrane proteins; obtain sample containing membrane protein, incubate with modulators, monitor activity, adjustment in membrane protein activity indicates modulator |
| 01/16/2003 | US20030013135 Spectrum analysis of macromolecules; obtain cell, expose to radio frequency, recover and analyze data |
| 01/16/2003 | US20030013133 Detection of a biological target |
| 01/16/2003 | US20030013132 Non-invasive localization of a light-emitting conjugate in a mammal |
| 01/16/2003 | US20030013125 Compound for use in drug development |
| 01/16/2003 | US20030013122 Methods and compositions for using MHC class II invariant chain polypeptide as a receptor for macrophage migration inhibitory factor |
| 01/16/2003 | US20030013120 Protein profiling system for use in monitoring preferential gene expression patterns |
| 01/16/2003 | US20030013117 Separation of nucleotide sequences in preferential pools; obtain nucleotide sequences, incubate with sequestering agents, separate reaction mixture, release pools of nucleotide sequences |
| 01/16/2003 | US20030013116 Multiplex protein interaction determinations using glutathione-GST binding |
| 01/16/2003 | US20030013115 Capillary array-based sample screening |
| 01/16/2003 | US20030013114 Nucleic acid affinity columns |
| 01/16/2003 | US20030013113 Detection of binding domain in polypeptide; obtain polypeptide, incubate with ligand, expose spectrum analysis, detect binding domain in protein |
| 01/16/2003 | US20030013112 Nucleic acid isolation from stool samples and other inhibitor-rich biological materials |
| 01/16/2003 | US20030013111 Method and apparatus for solid state molecular analysis |
| 01/16/2003 | US20030013110 Monitoring protein interaction with nucleotide sequences in sample; obtain sample of nucleotide sequence, incubate with protein, monitor transcriptional activity in cells |
| 01/16/2003 | US20030013109 Hairpin sensors using quenchable fluorescing agents |
| 01/16/2003 | US20030013108 Novel RIP3 associated cell cycle proteins, compositions and methods of use |
| 01/16/2003 | US20030013104 Monitoring the effectiveness of bactericide; obtain resistant bacterial cell, incubate with bactericide, monitor bacterial response to bactericide |
| 01/16/2003 | US20030013103 Apparatus and method for detecting and identifying infectious agents |
| 01/16/2003 | US20030013101 Polynucleotide sequencing |
| 01/16/2003 | US20030013100 Nucleic acid reading and analysis system |
| 01/16/2003 | US20030013099 Genes regulated by DNA methylation in colon tumors |
| 01/16/2003 | US20030013098 Detection of preferential nucleotide sequences in sample; obtain sample, expose to endonuclease, incubate with oligonucleotides, detect cleavage products |
| 01/16/2003 | US20030013097 Genes overexpressed in prostate disorders as diagnostic and therapeutic targets |
| 01/16/2003 | US20030013096 Generation of nucleotide sequence detector; obtain particles containing metal and protein, incubate in reaction mix, remove protein, bond nucleotide sequence particles to metal |
| 01/16/2003 | US20030013095 Nuclcic acid enzyme for use in the prevention and treatment of infections and cancer |
| 01/16/2003 | US20030013094 Apparatus for use in the detection of preferential nucleotide sequences in sample |
| 01/16/2003 | US20030013093 Diagnosis of diabetes and insulin resistance in humans; obtain adipose cells, extract nucleotide sequences, determine gene expression patterns, evaluate for diabetes and insulin resistance |
| 01/16/2003 | US20030013092 Composition for use in high temperature hybridization of oligonucleotides |
| 01/16/2003 | US20030013091 Methods for detection and quantification of analytes in complex mixtures |
| 01/16/2003 | US20030013090 Methods of diagnosing multidrug resistant tuberculosis |
| 01/16/2003 | US20030013087 Novel mutations in the freac3 gene for diagnosis and prognosis of glaucoma and anterior segment dysgenesis |
| 01/16/2003 | US20030013084 Organometallic probe |
| 01/16/2003 | US20030013083 Particle analysis as a detection system for particle-enhanced assays |
| 01/16/2003 | US20030013082 Evaluation of effectiveness of herbal medicines in the treatment and prevention of viral infections; obtain cells, incubate with viricide, monitor viral gene expression, decrease in viral gene expression indicates viricides |
| 01/16/2003 | US20030013079 Generation of preferential viral particle; obtain cells, transform with expresion vector, culture cell, recover viral particle |
| 01/16/2003 | US20030013078 Expression vector for use in the prevention and treatment of vial infection |
| 01/16/2003 | US20030012777 Polymer conjugates of proteinases |
| 01/16/2003 | US20030012695 Substrates comprising polynucleotide microarrays |
| 01/16/2003 | US20030012689 Apparatus for testing sterilization methods and materials |
| 01/16/2003 | CA2812821A1 Dna sequences comprising gene transcription regulatory qualities and methods for detecting and using such dna sequences |
| 01/16/2003 | CA2812799A1 Dna sequences comprising gene transcription regulatory qualities and methods for detecting and using such dna sequences |
| 01/16/2003 | CA2798555A1 Methods for detection and quantification of analytes in complex mixtures |
| 01/16/2003 | CA2519161A1 Sir2 activity |
| 01/16/2003 | CA2455490A1 Delivery of dsrna to arthropods |
| 01/16/2003 | CA2453207A1 Method for isolation of independent, parallel chemical micro-reactions using a porous filter |
| 01/16/2003 | CA2453195A1 Sir2 activity |
| 01/16/2003 | CA2453173A1 Mycobacterial antigens expressed during latency |
| 01/16/2003 | CA2453100A1 Novel human hepatoma lines, methods for obtaining same and uses thereof |
| 01/16/2003 | CA2453098A1 Methods of diagnosis of bladder cancer, compositions and methods of screening for modulators of bladder cancer |
| 01/16/2003 | CA2453075A1 Drug metabolizing enzymes |
| 01/16/2003 | CA2453068A1 Mesenchymal cells and osteoblasts from human embryonic stem cell |
| 01/16/2003 | CA2452849A1 Method for monitoring and modulating protein folding |
| 01/16/2003 | CA2452628A1 Methylation of histone h4 at arginine 3 |
| 01/16/2003 | CA2452578A1 Ephrin and eph receptor mediated immune modulation |
| 01/16/2003 | CA2452501A1 Secreted proteins |
| 01/16/2003 | CA2452396A1 Method of producing template dna and method of producing protein in cell-free protein synthesis system using the same |
| 01/16/2003 | CA2452315A1 Expression of functional human olfactory cyclic nucleotide gated (cng) channel in recombinant host cells and use thereof in cell based assays to identify smell modulators |
| 01/16/2003 | CA2452241A1 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions |
| 01/16/2003 | CA2451395A1 Novel pgc-1 isoforms and uses therefor |
| 01/16/2003 | CA2451374A1 Aggrecanase molecules |
| 01/16/2003 | CA2451314A1 Droplet dispensing system |
| 01/16/2003 | CA2451193A1 Methods and compositions for modulating adenosine triphosphate (atp) in cells and preventing cell injury or death via post-translational modifications to atp synthase |
| 01/16/2003 | CA2451092A1 Identification of modulators of neurotransmitter activity of xanthurenic acid |
| 01/16/2003 | CA2450502A1 Epf receptor assays, compounds and therapeutic compositions |
| 01/16/2003 | CA2450256A1 Catalase-inactivating compounds and the use thereof |
| 01/16/2003 | CA2450236A1 Phage displayed pdz domain ligands |
| 01/16/2003 | CA2450194A1 Novel chromogenic substances and use thereof for the determination of carboxypeptidase activities |
| 01/16/2003 | CA2450020A1 Dna sequences comprising gene transcription regulatory qualities and methods for detecting and using dna sequences |
| 01/16/2003 | CA2353120A1 Caged compound cleaving process |
| 01/15/2003 | WO2002006467A1 Method of detecting lipid metabolic errors |
| 01/15/2003 | EP1275965A1 Method for identifying substances which modulate interleukin 4 (IL-4) signaling |
| 01/15/2003 | EP1275738A1 Method for random cDNA synthesis and amplification |
| 01/15/2003 | EP1275737A2 Compositions and processes for analyte detection; quantification and amplification |
| 01/15/2003 | EP1275736A1 Method for detection of frameshift mutations |